Millennium Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,000
Closed -$324K 6743
2023
Q2
$324K Hold
20,000
﹤0.01% 4831
2023
Q1
$348K Buy
+20,000
New +$360K ﹤0.01% 4817
2020
Q3
Sell
-40,000
Closed -$439K 4926
2020
Q2
$439K Buy
+40,000
New +$414K ﹤0.01% 3477
2020
Q1
Sell
-50,000
Closed -$804K 4682
2019
Q4
$804K Buy
50,000
+30,000
+150% +$496K ﹤0.01% 3109
2019
Q3
$313K Hold
20,000
﹤0.01% 3545
2019
Q2
$398K Sell
20,000
-90,000
-82% -$1.68M ﹤0.01% 3377
2019
Q1
$1.85M Buy
110,000
+80,000
+267% +$1.39M ﹤0.01% 2462
2018
Q4
$455K Buy
+30,000
New +$515K ﹤0.01% 3024
2018
Q3
Sell
-272,900
Closed -$5.32M 4379
2018
Q2
$5.32M Buy
272,900
+122,900
+82% +$1.94M 0.01% 1776
2018
Q1
$2.05M Buy
+150,000
New +$1.98M ﹤0.01% 2299
2017
Q3
Sell
-30,000
Closed -$516K 3966
2017
Q2
$516K Buy
+30,000
New +$456K ﹤0.01% 2789

Other funds holding NXGN

Millennium Management's NXGN Position: Q4 2023 in Review

Millennium Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 142,196 shares — an estimated $3.37M sold.

Millennium Management first reported a position in NXGN in Q2 2013 and held it in 33 quarters. The position peaked at $27.8M in Q4 2022. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Millennium Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 142,196 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $3.37M.
  • Millennium Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 33 quarters.
  • Millennium Management's NextGen Healthcare, Inc. Common Stock position peaked at $27.8M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.